Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Renalytix AI, Inc.
Age
23–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
23 years of age or older.
Clinical history of confirmed type 2 diabetes.
Evidence of DKD Stages 1-3:
Baseline eGFR of 30-59 ml/min/1.73m2 (confirmed 3 months apart with at least one value within 1 year prior to enrollment)
Individuals with eGFR ≥60 ml/min/1.73m2 and albuminuria (UACR ≥30mg/g)
All patients will have a HbA1c, eGFR, urine albumin and urine creatinine, eGFR, available from within 12 months of enrollment (to be obtained if not clinically available prior).
The subject must be able to comprehend and sign an approved informed consent form and other applicable study documents.
You may not be if
Patients with eGFR \<30 or ≥ 60 ml/min/1.73m2 without albuminuria.
Patients with ESRD or on renal recovery treatments at time of enrollment.
Patients who are pregnant at the time of enrollment.
Patients who are currently hospitalized.
Patients who are currently on Enbrel.
Clareo Health | Prospective Decision Impact Trial of KidneyIntelX
